Loading
Two more women die after taking abortion drug RU-486

.- Two pro-life groups are wondering why the Food and Drug Administration (FDA) still has not pulled Mifeprex, an abortion drug more commonly known as RU-486, after reporting March 17 that two more women died after taking it.

“How many women will have to die after taking this drug?” asked Randall O’Bannon of National Right to Life.

“One death is too many. But after at least seven American deaths and at least 12 reported deaths worldwide, it is clear that this drug should not be given to women,” said the organization’s director of education and research.

To date, the FDA has directly linked to the drug to the deaths of seven women. As well, the FDA has received more than 800 reports of complications caused by the drug. The FDA admits that only 10 percent of complications from drugs get reported.

An RU-486 abortion involves bleeding, pain, and cramping, often accompanied by nausea, vomiting, and diarrhea. The expectation of these side effects often causes women and doctors to overlook important signs of infection or serious conditions, like ectopic pregnancy.

National Right to Life claims that many deaths and injuries related to the drug may never be reported. Reporting is voluntary, and women going to the emergency room may never tell the doctor they have taken the drug, the organization explained in a press release.

In another communiqué, Concerned Women for America pointed out that the FDA has pulled other drugs that have caused fewer deaths and less severe complications than RU-486.

For example, NeutroSpec, an imaging agent used to diagnose internal infections, was pulled after being linked to two deaths, 20 severe reactions, and 46 other "less" severe reactions.

Tysabri, a drug to treat multiple sclerosis, was pulled after reports that three patients taking it had developed PML, a rare brain disease.

Lotronex, used to treat irritable bowel syndrome, was taken off the market after 70 patients had developed severe problems, and five patients died.

Given the statistics, the CWA is wondering why the FDA is slacking in pulling Mifeprex off the shelf. Mifeprex is distributed by Danco.


Ads by AdsLiveMedia(What's this?)

* The number of messages that can be online is limited. CNA reserves the right to edit messages for content and tone. Comments and opinions expressed by users do not necessarily reflect the opinions or beliefs of CNA. CNA will not publish comments with abusive language, insults or links to other pages

RESOURCES »

Ads by Google (What's this?)

Featured Videos

Presentation of the book "The Pastor"
Presentation of the book "The Pastor"
Synod on the Family October 2014
Preferential option for the poor
God is alive, even in sport
'A forbidden God' named Best Film at the International Catholic Film Festival
Vatican backs a 'Pause for Peace' during World Cup final
The effects of religious violence in Sarajevo 
The origin of Corpus Christi 
Corpus Christi at the Vatican 
Homage to an Indian Cardinal
Train of the Child's Light
New book explaining gestures of the Mass
Encounter between Pope Francis and the Charismatic Renewal in the Spirit Movement.
Religious tensions subside amid Balkan floods
John Paul II Center for Studies on Marriage and Family
Saint John Paul II on cartoon
Syrian Christian refugees
Papal Foundation Pilgrimage
Exorcism or prayer of liberation?
First meeting of Commission for Protection of Minors
Jul
23

Liturgical Calendar

July 23, 2014

Wednesday of the Sixteenth Week in Ordinary Time

All readings:
Today »
This year »

Catholic Daily

Gospel of the Day

Mt 13:1-9

Gospel
Date
07/23/14
07/20/14
07/19/14

Daily Readings


First Reading:: Jer 1:1, 4-10
Gospel:: Mt 13: 1-9

Saint of the Day

St. John Cassian »

Saint
Date
07/23/14

Homily of the Day

Mt 13:1-9

Homily
Date
07/23/14
07/21/14
07/20/14

Ads by AdsLiveMedia.com

Ads by AdsLiveMedia.com
     HTML
Text only
Headlines
  

Follow us: